Anika Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Anika Therapeutics Inc.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
/ 
Frequently asked questions
To buy Anika Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Anika Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Anika Therapeutics Inc. is ANIK:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Anika Therapeutics Inc. has its primary listing on NASDAQ. You can trade Anika Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Anika Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Anika Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Anika Therapeutics Inc. or others.